Berita

Moderna Maintains Vaccine Sales View on Lower COVAX Orders

Rabu, 03 Agustus 2022 | 19:16 WIB
Moderna Maintains Vaccine Sales View on Lower COVAX Orders

ILUSTRASI. Moderna Inc on Wednesday retained its full-year sales outlook for Covid-19 shot at US$ 21 billion due to a decrease in orders from low- and middle-income countries. REUTERS/Michele Tantussi

Sumber: Reuters | Editor: Anastasia Lilin Yuliantina

KONTAN.CO.ID - Moderna Inc on Wednesday retained its full-year sales outlook for Covid-19 shot at US$ 21 billion due to a decrease in orders from low- and middle-income countries through the COVAX international vaccine-sharing program.

The company kept its forecast unchanged despite announcing a new US$ 1,74 billion deal with the US government for 66 million Covid-19 booster doses last week.

Terbaru
IHSG
6.892,57
1.36%
-94,76
LQ45
961,84
1.77%
-17,31
USD/IDR
15.409
-0,13
EMAS
984.000
1,50%